Maternal pertussis vaccination has been introduced in several countries to protect infants
from birth until routine infant vaccination takes place. This review assesses existing …

With birth, the newborn is transferred from a quasi-sterile environment to the outside world.
At this time, the neonatal immune system is inexperienced and continuously subject to a …

Background England's third-trimester maternal pertussis vaccination, introduced in October
2012, was extended to the second trimester in 2016. Maternal vaccination provides high …

Importance Maternal tetanus, diphtheria, and acellular pertussis (Tdap) vaccination protects
newborns against severe pertussis. Data on transplacental antibody transfer on Tdap …

Background Pertussis vaccination in pregnancy is recommended in many countries to
provide protection to young infants. The best timing for this vaccination is uncertain. In the …

Background Maternal immunisation is an important strategy to reduce neonatal mortality and
morbidity. New maternal vaccines such as Respiratory Syncytial Virus (RSV) and Group B …

ABSTRACT The Maternal Neonatal Tetanus Elimination program is proof of concept for the
feasibility and potential for maternal immunization to reduce neonatal mortality particularly in …

Background Respiratory syncytial virus (RSV) infection is an important cause of infant
mortality. Here, we estimated the potential impact of maternal vaccination against RSV on …

Abstract Background In October 2012, a maternal pertussis vaccination program was
introduced in England for women between 28 and 32 weeks of pregnancy. In April 2016, the …

Background Pertussis causes severe disease in young unvaccinated infants, with preterms
potentially at highest risk. We studied pertussis in hospitalized infants as related to …